All articles by  

  1. Augusta University develops new chimera molecule for breast cancer

    Researchers from the Georgia Cancer Center at Augusta University have developed a tripartite chimera molecule to treat some types of…
    Read More…

    26 Mar
  2. Eisai and Merck get Japanese regulatory approval for Lenvima

    Eisai and Merck have received the regulatory approval for the use of Lenvima to treat unresectable hepatocellular carcinoma (HCC) patients…
    Read More…

    26 Mar
  3. European CHMP recommends Sandoz’s biosimilar infliximab

    The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced a positive opinion…
    Read More…

    26 Mar
  4. Novartis’ Tasigna gets FDA approval for rare leukaemia in children

    Novartis has received approval from the US Food and Drug Administration (FDA) for the use of its Tasigna (nilotinib) drug…
    Read More…

    23 Mar
  5. Japan’s Shionogi signs CARB-X partnership to tackle CRE superbug

    Japanese pharmaceutical firm Shionogi has entered into a collaborative agreement with CARB-X to address growing drug-resistant bacteria. The collaboration will focus…
    Read More…

    23 Mar
  6. Study finds 62% of drug safety experts prefer AI

    A new study conducted by Oracle Health Sciences and Informa Engage/Pharma Intelligence has showed that 62% of drug safety experts…
    Read More…

    23 Mar
  7. Regeneron and Alnylam to find new RNAi drugs for NASH disease

    Regeneron Pharmaceuticals has formed an alliance with Alnylam Pharmaceuticals to discover RNA interference (RNAi) therapeutics for the treatment of nonalcoholic…
    Read More…

    22 Mar
  8. Helsinn to purchase skin cancer drug Valchlor from Actelion

    Swiss pharmaceutical group Helsinn has signed a definitive agreement with Actelion Pharmaceuticals to obtain worldwide rights to Valchlor/Ledaga (mechlorethamine/chlormethine) for…
    Read More…

    22 Mar
  9. AbbVie forms new partnership to better study multiple myeloma

    AbbVie has collaborated with the International Myeloma Foundation (IMF) to perform a retrospective chart review study to gain insights into…
    Read More…

    22 Mar
  10. UK joins efforts to develop new medical treatments using X-ray

    The UK has signed the European X-Ray Free-Electron Laser (XFEL) convention in Berlin, Germany. The convention focuses on the development…
    Read More…

    21 Mar
Close
Close
Close

Go Top